{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:46:32Z","timestamp":1777340792115,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cobel Darou"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.yebeh.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:05:05Z","timestamp":1552680305000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Levetiracetam versus carbamazepine in treatment of rolandic epilepsy"],"prefix":"10.1016","volume":"94","author":[{"given":"Ali A.","family":"Asadi-Pooya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahta","family":"Forouzesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Eidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Emad","family":"Mirzaghafour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.02.009_bb0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/archdischild-2013-304211","article-title":"Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility","volume":"100","author":"Mellish","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yebeh.2018.04.002","article-title":"Language skills in children with benign childhood epilepsy with centrotemporal spikes: a systematic review","volume":"84","author":"Teixeira","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0015","doi-asserted-by":"crossref","first-page":"407e12","DOI":"10.1111\/j.1469-8749.2001.tb00229.x","article-title":"Neuropsychological disorders related to interictal epileptic discharges during sleep in benign epilepsy of childhood with centrotemporal or rolandic spikes","volume":"43","author":"Baglietto","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pediatrneurol.2012.06.009","article-title":"Does a normalizing electroencephalogram in benign childhood epilepsy with centrotemporal spikes abort attention deficit hyperactivity disorder?","volume":"47","author":"Schneebaum-Sender","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yebeh.2005.07.001","article-title":"Acoustic effects of carbamazepine in benign rolandic epilepsy","volume":"7","author":"Park","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/11316250-000000000-00000","article-title":"Levetiracetam in childhood epilepsy","volume":"12","author":"Verrotti","year":"2010","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0035","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1212\/WNL.0000000000001661","article-title":"Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy","volume":"84","author":"Jung","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pediatrneurol.2006.09.018","article-title":"Levetiracetam monotherapy in children with epilepsy","volume":"36","author":"Khurana","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/dmcn.13628","article-title":"Reading comprehension difficulties in children with rolandic epilepsy","volume":"60","author":"Currie","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0050","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1590\/0004-282X20140141","article-title":"Rolandic epilepsy and dyslexia","volume":"72","author":"Oliveira","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0055","first-page":"209","article-title":"Psychiatric and neurocognitive evaluation focused on frontal lobe functions in rolandic epilepsy","volume":"50","author":"Ayaz","year":"2013","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejpn.2013.01.001","article-title":"Clinical evaluation of language fundamentals in Rolandic epilepsy, an assessment with CELF-4","volume":"17","author":"Overvliet","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.yebeh.2012.04.131","article-title":"Neuropsychological assessment of children with rolandic epilepsy: executive functions","volume":"24","author":"Neri","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0070","first-page":"114","article-title":"A neuropsychological assessment, using computerized battery tests (CANTAB), in children with benign rolandic epilepsy before AED therapy","volume":"5","author":"Vin\u0163an","year":"2012","journal-title":"J Med Life"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2009.10.004","article-title":"Neuropsychological aspects of benign childhood epilepsy with centrotemporal spikes","volume":"19","author":"Goldberg-Stern","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2011.02.009","article-title":"Impaired language performance as a precursor or consequence of Rolandic epilepsy?","volume":"304","author":"Overvliet","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S0104-56872010000300009","article-title":"School performance and praxis assessment in children with Rolandic epilepsy","volume":"22","author":"Oliveira","year":"2010","journal-title":"Pro Fono"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1469-8749.2008.02040.x","article-title":"Academic performance in children with rolandic epilepsy","volume":"50","author":"Piccinelli","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/08830738060210062601","article-title":"Longitudinal assessment of neuropsychologic and language function in children with benign rolandic epilepsy","volume":"21","author":"Northcott","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0100","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1528-1167.2005.62304.x","article-title":"The neuropsychological and language profile of children with benign rolandic epilepsy","volume":"46","author":"Northcott","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.yebeh.2004.08.004","article-title":"Development of cognitive functions in children with rolandic epilepsy","volume":"5","author":"Lindgren","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.seizure.2005.01.009","article-title":"Educational problems with underlying neuropsychological impairment are common in children with benign epilepsy of childhood with centrotemporal spikes (BECTS)","volume":"14","author":"Vinayan","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yebeh.2004.09.008","article-title":"Written language skills in children with benign childhood epilepsy with centrotemporal spikes","volume":"6","author":"Papavasiliou","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1684\/j.1950-6945.2006.tb00154.x","article-title":"Cognitive functions in children with benign childhood epilepsy with centrotemporal spikes (BECTS)","volume":"8","author":"Pinton","year":"2006","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.seizure.2011.09.004","article-title":"CInAPCe Group. Impact of benign childhood epilepsy with centrotemporal spikes (BECTS) on school performance","volume":"21","author":"Miziara","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yebeh.2014.05.030","article-title":"Attention-deficit\/hyperactivity disorder and attention impairment in children with benign childhood epilepsy with centrotemporal spikes","volume":"37","author":"Kim","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bandl.2004.07.001","article-title":"Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: rolandic epilepsy and language","volume":"92","author":"Monjauze","year":"2005","journal-title":"Brain Lang"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pediatrneurol.2009.05.013","article-title":"Neuropsychologic impairment in children with rolandic epilepsy","volume":"41","author":"Ay","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0145","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.yebeh.2009.08.012","article-title":"Cognitive deficits in children with benign rolandic epilepsy of childhood or rolandic discharges: a study of children between 4 and 7 years of age with and without seizures compared with healthy controls","volume":"16","author":"Danielsson","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.yebeh.2013.04.005","article-title":"Neuropsychological impairment in children with Rolandic epilepsy and in their siblings","volume":"28","author":"Verrotti","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yebeh.2015.11.010","article-title":"Neuropsychological profile in new-onset benign epilepsy with centrotemporal spikes (BECTS): focusing on executive functions","volume":"54","author":"Filippini","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.yebeh.2006.12.003","article-title":"Intellectual and language findings and their relationship to EEG characteristics in benign childhood epilepsy with centrotemporal spikes","volume":"10","author":"Riva","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yebeh.2007.04.001","article-title":"Epileptiform EEG discharges in benign childhood epilepsy with centrotemporal spikes: reactivity and transitory cognitive impairment","volume":"11","author":"Fonseca","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0170","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1528-1167.2007.01203.x","article-title":"EEG characteristics related to educational impairments in children with benign childhood epilepsy with centrotemporal spikes","volume":"48","author":"Nicolai","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0175","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ejpn.2017.07.001","article-title":"Influence of epileptic activity during sleep on cognitive performance in benign childhood epilepsy with centrotemporal spikes","volume":"21","author":"Nissenkorn","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yebeh.2017.11.007","article-title":"The influence of EEG-detected nocturnal centrotemporal discharges on the expression of core symptoms of ADHD in children with benign childhood epilepsy with centrotemporal spikes (BCECTS): a prospective study in a tertiary referral center","volume":"79","author":"Danhofer","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.yebeh.2011.08.008","article-title":"Reading performance in children with rolandic epilepsy correlates with nocturnal epileptiform activity, but not with epileptiform activity while awake","volume":"22","author":"Ebus","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1212\/WNL.0000000000002358","article-title":"Real-time effects of centrotemporal spikes on cognition in rolandic epilepsy: an EEG-fMRI study","volume":"86","author":"Xiao","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0195","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yebeh.2007.07.011","article-title":"A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy","volume":"11","author":"Kossoff","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2018.10.002","article-title":"Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy","volume":"62","author":"Kanemura","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0205","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fnins.2018.00796","article-title":"Antiepileptic drug of levetiracetam decreases centrotemporal spike-associated activation in rolandic epilepsy","volume":"12","author":"Zhang","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0210","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1528-1157.2000.tb04606.x","article-title":"Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group","volume":"41","author":"Rating","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0215","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/08830738020170123004","article-title":"Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes","volume":"17","author":"Kramer","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.yebeh.2005.07.012","article-title":"Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation","volume":"7","author":"Tzitiridou","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.braindev.2006.09.008","article-title":"Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial","volume":"29","author":"Coppola","year":"2007","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejpn.2013.03.014","article-title":"Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD study)","volume":"17","author":"Borggraefe","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0235","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.seizure.2014.06.006","article-title":"Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS)","volume":"23","author":"Xiao","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0240","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00381-016-3043-0","article-title":"Nightly oral administration of topiramate for benign childhood epilepsy with centrotemporal spikes","volume":"32","author":"Liu","year":"2016","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3988\/jcn.2018.14.4.523","article-title":"Effects of antiepileptic drugs on language abilities in benign epilepsy of childhood with centrotemporal spikes","volume":"14","author":"Han","year":"2018","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.seizure.2006.12.006","article-title":"Levetiracetam monotherapy for children and adolescents with benign rolandic seizures","volume":"16","author":"Verrotti","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0255","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/dmcn.12856","article-title":"A meta-analysis of literacy and language in children with rolandic epilepsy","volume":"57","author":"Smith","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0260","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1528-1167.2008.01610.x","article-title":"Attention impairment in rolandic epilepsy: systematic review","volume":"49","author":"Kavros","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0265","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/epi.13865","article-title":"Cognitive functioning in children with self-limited epilepsy with centrotemporal spikes: a systematic review and meta-analysis","volume":"58","author":"Wickens","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yebeh.2005.08.016","article-title":"Cognitive and behavioral effects of nocturnal epileptiform discharges in children with benign childhood epilepsy with centrotemporal spikes","volume":"8","author":"Nicolai","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11910-018-0892-9","article-title":"The impact of Interictal discharges on performance","volume":"18","author":"Faught","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0280","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5698\/1535-7511-12.5.192","article-title":"The relationship between nocturnal discharges and language dysfunction in rolandic epilepsy: treat the child, not the adage","volume":"12","author":"Buchhalter","year":"2012","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0285","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.clinph.2011.09.012","article-title":"Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-na\u00efve epilepsy patients","volume":"123","author":"Cho","year":"2012","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0290","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yebeh.2014.12.007","article-title":"Incidental rolandic spikes: long-term outcomes and impact of treatment","volume":"43","author":"McNally","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0295","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yebeh.2010.02.011","article-title":"Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial","volume":"18","author":"Helmstaedter","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0300","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2147\/NDT.S151413","article-title":"A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy","volume":"14","author":"Zhang","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2019.02.009_bb0305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40263-015-0248-9","article-title":"Levetiracetam monotherapy in children with epilepsy: a systematic review","volume":"29","author":"Weijenberg","year":"2015","journal-title":"CNS Drugs"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019301143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019301143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:26:17Z","timestamp":1761503177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019301143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":61,"alternative-id":["S1525505019301143"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.02.009","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam versus carbamazepine in treatment of rolandic epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}